Phase 2CompletedAge-related condition

Melatonin and the Metabolic Syndrome (MetSyn)

Melatonin Supplementation and the Metabolic Syndrome: A Phase II Crossover Design Clinical Trial

Sponsor
Emory University (Academic or other)
Enrollment
39 enrolled
Conditions
Metabolic Syndrome
Interventions
Melatonin; Placebo
Ages
adults, older adults
Registry
NCT01038921

Full record on ClinicalTrials.gov

From the registry

This trial seeks to compare the effects of melatonin supplementation versus placebo in subjects with the metabolic syndrome.

Primary outcomes

  • Metabolic Syndrome Components

History

  1. Last registry update

  2. Results first posted

  3. Study completion

  4. Primary completion

  5. Registered

  6. Started

Papers citing this trial